Wikidata

(Q47792376)

English

A phase 2a, open-label pilot study of the galectin-3 inhibitor GR-MD-02 for the treatment of moderate-to-severe plaque psoriasis

scientific article published in October 2017

In more languages

Statements

title
A phase 2a, open-label pilot study of the galectin-3 inhibitor GR-MD-02 for the treatment of moderate-to-severe plaque psoriasis (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
28917454
retrieved
5 February 2018
reference URL
http://europepmc.org/abstract/MED/28917454

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q47792376&oldid=2171129529"